Terms: = Breast cancer AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71 AND Treatment
44 results:
1. Evaluation of biosimilar trastuzumab myl-1401O in HER2-positive breast cancer.
Eser K; Sezer E; Erçolak V; İnal A
Am J Manag Care; 2023 Feb; 29(2):e36-e42. PubMed ID: 36811986
[TBL] [Abstract] [Full Text] [Related]
2. Progressive multifocal leukoencephalopathy, advanced ductal breast carcinoma, systemic sclerosis, and checkpoint inhibitors: a therapeutic dilemma.
Baena-Álvarez B; Rodríguez-Jorge F; Beltrán-Corbellini Á; Cortés-Salgado A; De la Puente C; Corral Í
J Neurovirol; 2023 Feb; 29(1):116-119. PubMed ID: 36348234
[TBL] [Abstract] [Full Text] [Related]
3. Clinical application of low-level laser therapy (Photo-biomodulation therapy) in the management of breast cancer-related lymphedema: a systematic review.
Mahmood D; Ahmad A; Sharif F; Arslan SA
BMC Cancer; 2022 Aug; 22(1):937. PubMed ID: 36042421
[TBL] [Abstract] [Full Text] [Related]
4. Accuracy of tumor registry versus pharmacy dispensings for breast cancer adjuvant endocrine therapy.
Haas CB; Bowles EJA; Lee JM; Specht J; Buist DSM
Cancer Causes Control; 2022 Sep; 33(9):1145-1153. PubMed ID: 35796846
[TBL] [Abstract] [Full Text] [Related]
5. Trastuzumab biosimilars vs trastuzumab originator in the treatment of HER2-positive breast cancer: a systematic review and network meta-analysis.
Liu T; Liu D; Jin Y; Dong M
Immunopharmacol Immunotoxicol; 2022 Dec; 44(6):809-815. PubMed ID: 35708278
[TBL] [Abstract] [Full Text] [Related]
6. Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer.
Liu J; Wang Y; Tian Z; Lin Y; Li H; Zhu Z; Liu Q; Su S; Zeng Y; Jia W; Yang Y; Xu S; Yao H; Jiang W; Song E
Nat Commun; 2022 May; 13(1):3011. PubMed ID: 35641481
[TBL] [Abstract] [Full Text] [Related]
7. Long-Term Effectiveness of Combined Intermittent Pneumatic Compression Plus Low-Level Laser Therapy in Patients with Postmastectomy Lymphedema: A Randomized Controlled Trial.
Kozanoglu E; Gokcen N; Basaran S; Paydas S
Lymphat Res Biol; 2022 Apr; 20(2):175-184. PubMed ID: 33826415
[No Abstract] [Full Text] [Related]
8. Mutational profiling of micro-dissected pre-malignant lesions from archived specimens.
Nachmanson D; Steward J; Yao H; Officer A; Jeong E; O'Keefe TJ; Hasteh F; Jepsen K; Hirst GL; Esserman LJ; Borowsky AD; Harismendy O
BMC Med Genomics; 2020 Nov; 13(1):173. PubMed ID: 33208147
[TBL] [Abstract] [Full Text] [Related]
9. Intrinsically Disordered SRC-3/AIB1 Protein Undergoes Homeostatic Nuclear Extrusion by Nuclear Budding While Ectopic Expression Induces Nucleophagy.
Cabrita MA; Renart LI; Lau R; Pratt MAC
Cells; 2019 Oct; 8(10):. PubMed ID: 31635050
[TBL] [Abstract] [Full Text] [Related]
10. Targeting pml in triple negative breast cancer elicits growth suppression and senescence.
Arreal L; Piva M; Fernández S; Revandkar A; Schaub-Clerigué A; Villanueva J; Zabala-Letona A; Pujana M; Astobiza I; Cortazar AR; Hermanova I; Bozal-Basterra L; Arruabarrena-Aristorena A; Crespo JR; Valcarcel-Jimenez L; Zúñiga-García P; Canals F; Torrano V; Barrio R; Sutherland JD; Alimonti A; Martin-Martin N; Carracedo A
Cell Death Differ; 2020 Apr; 27(4):1186-1199. PubMed ID: 31570853
[TBL] [Abstract] [Full Text] [Related]
11. Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar myl-1401H in the prophylactic treatment of chemotherapy-induced neutropenia.
Waller CF; Ranganna GM; Pennella EJ; Blakeley C; Bronchud MH; Mattano LA; Berzoy O; Voitko N; Shparyk Y; Lytvyn I; Rusyn A; Popov V; Láng I; Beckmann K; Sharma R; Baczkowski M; Kothekar M; Barve A
Ann Hematol; 2019 May; 98(5):1217-1224. PubMed ID: 30824956
[TBL] [Abstract] [Full Text] [Related]
12. S100A3 a partner protein regulating the stability/activity of RARα and pml-RARα in cellular models of breast/lung cancer and acute myeloid leukemia.
Gianni M; Terao M; Kurosaki M; Paroni G; Brunelli L; Pastorelli R; Zanetti A; Lupi M; Acquavita A; Bolis M; Fratelli M; Rochette-Egly C; Garattini E
Oncogene; 2019 Apr; 38(14):2482-2500. PubMed ID: 30532072
[TBL] [Abstract] [Full Text] [Related]
13. Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer.
Naorem LD; Muthaiyan M; Venkatesan A
J Cell Biochem; 2019 Apr; 120(4):6154-6167. PubMed ID: 30302816
[TBL] [Abstract] [Full Text] [Related]
14. Regulation of cell surface protease receptor S100A10 by retinoic acid therapy in acute promyelocytic leukemia (APL)
Holloway RW; Thomas ML; Cohen AM; Bharadwaj AG; Rahman M; Marcato P; Marignani PA; Waisman DM
Cell Death Dis; 2018 Sep; 9(9):920. PubMed ID: 30206209
[TBL] [Abstract] [Full Text] [Related]
15. A pharmacokinetics phase 1 bioequivalence study of the trastuzumab biosimilar myl-1401O vs. EU-trastuzumab and US-trastuzumab.
Waller CF; Vutikullird A; Lawrence TE; Shaw A; Liu MS; Baczkowski M; Sharma R; Barve A; Goyal P; Donnelly C; Sengupta N; Pennella EJ
Br J Clin Pharmacol; 2018 Oct; 84(10):2336-2343. PubMed ID: 29926514
[TBL] [Abstract] [Full Text] [Related]
16. Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage breast cancer.
Goodman CR; Seagle BL; Friedl TWP; Rack B; Lato K; Fink V; Cristofanilli M; Donnelly ED; Janni W; Shahabi S; Strauss JB
JAMA Oncol; 2018 Aug; 4(8):e180163. PubMed ID: 29800954
[TBL] [Abstract] [Full Text] [Related]
17. The efficacy and safety of targeted therapy with or without chemotherapy in advanced gastric cancer treatment: a network meta-analysis of well-designed randomized controlled trials.
Zhao TT; Xu H; Xu HM; Wang ZN; Xu YY; Song YX; Yin SC; Liu XY; Miao ZF
Gastric Cancer; 2018 May; 21(3):361-371. PubMed ID: 29455269
[TBL] [Abstract] [Full Text] [Related]
18. NEMO, a Transcriptional Target of Estrogen and Progesterone, Is Linked to Tumor Suppressor pml in breast cancer.
Elsarraj HS; Valdez KE; Hong Y; Grimm SL; Ricci LR; Fan F; Tawfik O; May L; Cusick T; Inciardi M; Redick M; Gatewood J; Winblad O; Hilsenbeck S; Edwards DP; Hagan CR; Godwin AK; Fabian C; Behbod F
Cancer Res; 2017 Jul; 77(14):3802-3813. PubMed ID: 28515148
[TBL] [Abstract] [Full Text] [Related]
19. Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects.
Mori F; Ferraiuolo M; Santoro R; Sacconi A; Goeman F; Pallocca M; Pulito C; Korita E; Fanciulli M; Muti P; Blandino G; Strano S
Oncotarget; 2016 Apr; 7(15):20532-48. PubMed ID: 26967561
[TBL] [Abstract] [Full Text] [Related]
20. Barnacle: detecting and characterizing tandem duplications and fusions in transcriptome assemblies.
Swanson L; Robertson G; Mungall KL; Butterfield YS; Chiu R; Corbett RD; Docking TR; Hogge D; Jackman SD; Moore RA; Mungall AJ; Nip KM; Parker JD; Qian JQ; Raymond A; Sung S; Tam A; Thiessen N; Varhol R; Wang S; Yorukoglu D; Zhao Y; Hoodless PA; Sahinalp SC; Karsan A; Birol I
BMC Genomics; 2013 Aug; 14():550. PubMed ID: 23941359
[TBL] [Abstract] [Full Text] [Related]
[Next]
